NGS and Medicare: Does It Cover Genetic Sequencing?

NGS Medicare questions usually come down to one thing: will Medicare help pay for next-generation sequencing? The short answer is sometimes. Medicare covers certain NGS tests when they are ordered by a doctor and meet specific medical rules, especially for advanced cancer.

This guide explains what NGS is in plain language, when Medicare tends to cover it, and how to check before you test. No prior genetics knowledge needed.

Frequently asked questions

What does NGS mean?

NGS stands for next-generation sequencing, a laboratory technology that reads many genes at once. It lets labs scan large parts of your DNA quickly to look for genetic changes that may explain or predict a health condition.

Does Medicare cover NGS testing?

Medicare covers some NGS tests, most clearly for advanced cancer and certain inherited cancer risk cases that meet national criteria. Coverage requires a physician’s order and proof the test is medically necessary for your situation.

Does Medicare pay for rare disease gene testing?

Coverage for rare disease NGS is narrower and case-by-case. Medicare has no broad national rule covering all rare disease sequencing, so approval often depends on documented medical necessity and local coverage decisions. Even so, good preparation can change the outcome — we explain how below.

How do I find out if my test is covered?

Ask the ordering clinician and the testing lab whether the specific test has a Medicare coverage decision. You can also contact Medicare directly and request a written estimate of your expected out-of-pocket cost.

Will I owe money if Medicare denies the test?

Possibly. If a test may not be covered, the lab should give you an Advance Beneficiary Notice explaining you could be responsible for payment. Review it carefully before agreeing to the test.

What is NGS, in simple terms?

Your body follows instructions written in DNA. Genes are sections of that instruction manual, and small spelling changes in a gene can affect how a protein is made, which can lead to disease.

Next-generation sequencing is a technology that reads huge amounts of DNA at once. Instead of checking one gene at a time, a lab can scan hundreds of genes — or your whole exome — in a single run.

This speed is why doctors use NGS to look for the cause of cancers, inherited conditions, and many rare diseases.

When does Medicare cover NGS?

Medicare is a U.S. federal health program mainly for people 65 and older and some younger people with disabilities. It does not cover every test — it covers services judged medically necessary.

The clearest coverage is for cancer. Medicare has a national decision (NCD 90.2) covering certain NGS tests for patients with advanced cancer, used to guide treatment choices. Details are published in the public health genomics resources and in Medicare’s own coverage documents.

Common situations Medicare may cover

• Advanced (recurrent, metastatic, or stage III/IV) cancer, when the test helps choose therapy.
• Inherited (germline) cancer testing for patients who meet defined criteria. Today, germline coverage is defined fairly narrowly, centering on hereditary breast and ovarian cancer with a clinical indication and documented risk factors.
• Tests performed in a Medicare-approved lab and ordered by a treating physician.

Situations that are often not covered

• Broad screening in a healthy person with no symptoms or qualifying diagnosis.
• Repeat testing that duplicates results you already have.
• Some rare disease panels without a documented, specific medical need.

NGS for rare disease and Medicare: practical ways to improve your odds

Rare diseases are individually uncommon but collectively affect millions. Many are genetic, and NGS is often the fastest route to a diagnosis. You can explore condition details through OMIM (https://www.omim.org/) and the GARD rare disease center (https://rarediseases.info.nih.gov/).

Here is the honest part: Medicare does not have one broad rule that covers all rare disease sequencing. Coverage for these tests is often decided case by case, and it can depend on your region’s local coverage determination (LCD). But that does not mean it comes down to luck. How you prepare and document the request can make a real difference.

Preparation that improves the odds of approval

• Specific clinical detail and diagnosis codes: instead of a vague diagnosis, documentation of the patient’s symptoms and phenotype backed by precise diagnosis codes (ICD-10) makes medical necessity easier to establish.
• Evidence of medical necessity: the record should show what testing was done before, whether single-gene testing was inconclusive, relevant family history, and how the results could change treatment and management.
• A physician’s Letter of Medical Necessity: a document explaining why this NGS test — rather than another approach — is needed can help the review.

The role of a genetic counselor
A genetic counselor helps choose the right test for the symptoms, organizes the information that supports medical necessity, and helps prepare for prior authorization. They can explain both the medical value of a test and the practical coverage picture before you commit.

The role of the laboratory
An experienced genetic testing laboratory is an important partner on the diagnostic journey. A good lab identifies which local coverage determination (LCD) applies, guides the correct test coding, and supports prior authorization, benefits investigation, and appeals when needed.

How to check coverage before you test

A few simple steps can prevent an unexpected bill.

• Ask your clinician why this specific test is recommended and whether it has a Medicare coverage decision.
• Ask the testing lab for the test’s coverage status and an estimated cost if Medicare denies it.
• Read the Advance Beneficiary Notice (ABN) if you receive one — it means the test might not be covered and you could owe payment.
• Contact Medicare directly to confirm your plan’s rules.

Genetic counselors are especially helpful here. They can explain both the medical value of a test and the practical coverage picture before you commit.

When to talk to a professional

NGS can be a powerful tool, but coverage rules are detailed and change over time. If you or a family member is considering testing — for cancer, an inherited condition, or a suspected rare disease — speak with a clinician or genetic counselor. They can help decide whether NGS is right for your situation, order the correct test, and document the medical need that Medicare reviews.

* This guide is educational and is not medical or coverage advice for your individual case.

Last reviewed: July 2026 (Medicare NCD/LCD rules can change; please re-verify that this is current at the time of publishing or reuse.)

---

A rare disease journey can feel overwhelming. 3billion specializes in rare disease sequencing and supports clinicians through both testing and coverage questions. Learn more about 3billion’s testing lineup.